Do you want to read an article? Please log in or register.
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism
Thrombosis and Stroke
Related content
Atrial Fibrillation
Major Bleeding With Apixaban vs Aspirin: A Subanalysis of the ARTESiA Randomized Clinical Trial
JAMA Cardiol
Siegal DM, Sticherling C, Healey JS, McIntyre WF, Christensen LS, Parkash R, Vanassche T, Conen D, Gold M, Granger CB, Nielsen JC, Carrier M, Wojdyla DM, Erath JW, Rivard L, Kutyifa V, Wright DJ, Lopes RD
doi: 10.1001/jamacardio.2025.4151
Atrial Fibrillation
Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation
J Am Heart Assoc
Lip GYH, Cheng D, Jiang J, Gao C, Subash R, Vodicka E, Dubey A, Sharma PP, Vettumthara Unnikrishnan A, Mathivanan K, Deitelzweig S
doi: 10.1161/JAHA.125.044113
Myocardial Infarction
Clinical Outcomes of Complete Revascularization in Acute Myocardial Infarction Patients With High Bleeding Risk and Multivessel Disease
J Am Heart Assoc
Kim O, Joh HS, Kim HK, Kim JH, Hong YJ, Ahn Y, Jeong MH, Hur SH, Kim DI, Chang K, Park HS, Bae JW, Jeong JO, Park YH, Yun KH, Yoon CH, Kim Y, Hwang JY, Kim HS, Kwon W, Shin D, Choi KH, Park TK, Yang JH, Song YB, Hahn JY, Choi SH, Gwon HC, Lee SH, Lee JM, KAMIR Investigators
doi: 10.1161/JAHA.125.042507
Thrombosis and Stroke
Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients: A Post Hoc Analysis of the CLEAR Outcomes Randomized Clinical Trial
JAMA Cardiol
Spiazzi BF, Brennan D, Zingano CP, Powell HA, Nicholls SJ, Nissen SE, Laffin LJ
doi: 10.1001/jamacardio.2026.1208
COMMENTED
Cardiovascular Risk and DiseasesThrombosis and Stroke
Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
N Engl J Med
Skeith L, Bates SM
doi: 10.1056/NEJMra2202438
Heart, Artery and Coronary Diseases
Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk: A Systematic Review and Meta-Analysis
JAMA Cardiol
Zito A, Landi A, Bhatt DL, Chen SL, De Luca G, Franzone A, Gwon HC, Kang J, Hahn JY, Hong SJ, Jang Y, Kim BK, Kim HS, Kimura T, Mehran R, Park KW, Steg PG, Stone GW, Vranckx P, Windecker S, Valgimigli M
doi: 10.1001/jamacardio.2026.1922
Heart Failure
Kidney Tubular Biomarkers Predict Risk of Death and Heart Failure Readmission in Acute Heart Failure
J Am Heart Assoc
Wettersten N, Duff S, Horiuchi Y, van Veldhuisen DJ, Estrella MM, Shlipak MG, Maisel A, Murray PT, Ix JH
doi: 10.1161/JAHA.125.042880
Further Publications
Catheter-directed thrombectomy in acute pulmonary embolism and angiographic signs of chronic thromboembolic pulmonary disease
Clin Res Cardiol
Shahidi P, Mentzel L, Lauder L, Stojanovic S, Knorr M, Drummer KF, Sulimov D, Thiele H, Mahfoud F, Möbius-Winkler S, Piorkowski M, Hobohm L, Pöss J, Fengler K
doi: 10.1007/s00392-026-02893-8
Thrombosis and Stroke
Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study
Eur Stroke J
Frenger J, Jeker B, Arnold M, Grosse GM, Pokorny T, Westphal LP, Inauen C, Bicciato G, Arnold M, Fischer U, De Marchis GM, Kägi G, Kahles T, Cereda CW, Bustamante A, Montaner J, Ntaios G, Foerch C, Spanaus K, von Eckardstein A, Mueller D, Katan M
doi: 10.1177/23969873251366192